Friess Associates LLC Bristol Myers Squibb CO Transaction History

Friess Associates LLC

  • $59.9 Million
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$54.82 - $64.09 $13.2 Million - $15.4 Million
-240,000 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$46.4 - $67.43 $11.1 Million - $16.2 Million
240,000 New
240,000 $13.4 Million
Q2 2018

Aug 14, 2018
SELL
$50.53 - $62.98 $12.4 Million - $15.4 Million
-245,200 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$59.92 - $68.98 $14.7 Million - $16.9 Million
245,200 New
245,200 $15.5 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Friess Associates LLC Portfolio

Follow Friess Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Friess Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email